Fagron Genomics, together with Euro OTC Pharma, will participate in the Kongress für Integrative Medizin 2026, taking place from May 6 to 13 in Kos, Greece, one of the leading European meetings dedicated to integrative and interdisciplinary medical approaches.

As part of the scientific program, Dr Gustavo Torres de Souza, Lead Geneticist at Fagron Genomics, has been invited to deliver a lecture focused on personalized nutrition, weight management, and hormonal optimization in menopausal women.

This session will address one of the most complex and clinically relevant stages in women’s health, where metabolic changes, hormonal shifts, and lifestyle factors converge. Through a genetics-informed perspective, the lecture will explore how individual variability can be better understood and translated into more precise and actionable clinical strategies.

The integration of genetic insights into clinical practice enables healthcare professionals to move beyond standardized approaches.

In addition to his participation in the scientific program, Dr Gustavo Torres de Souza will also be available during the congress together with our colleagues from Euro OTC Pharma, engaging with healthcare professionals to answer questions, discuss clinical applications, and share how genetic testing can be integrated into routine practice. Attendees interested in learning more about the testing process will also have the opportunity to do so directly during the meeting.

Fagron Genomics’ participation in this congress reflects our ongoing commitment to advancing evidence-based personalization in everyday clinical practice, and to supporting healthcare professionals with tools that enhance decision-making and patient outcomes.

We look forward to contributing to this important scientific exchange in Kos and to connecting with professionals dedicated to the future of personalized and integrative medicine.